SB 706504
SB 706504 is a potent p38 MAPK inhibitor that inhibits Lipopolysaccharides (HY-D1056)-stimulated inflammatory gene expression in macrophages in chronic obstructive pulmonary disease (COPD).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 911110-38-8
- Formule: C24H19F3N8O
- Masse moléculaire:492.46
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
SB 706504(3 μM, 6 h) significantly reduces IL-1β, IL-6, GM-CSF, TNFα and IL-8 mRNA levels in LPS-stimulated monocyte derived macrophages (MDMs) cells[1].
SB 706504(3 μM, 6 h) can significantly reduce the level of TNFα induced by LPS in alveolar macrophages (AMs) cells of COPD patients, with an inhibition rate of 67.4%[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 911110-38-8
-
Masse moléculaire 492.46
-
Formule C24H19F3N8O
-
SMILES
N=C(NCCNC1=NC(C2=CC=C(F)C=C2C)=C(C=CC(N3C4=C(F)C=CC=C4F)=O)C3=N1)NC#N
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)